Correlation Engine 2.0
Clear Search sequence regions

  • apoptosis (10)
  • BAK (3)
  • BAX (2)
  • drug targets (1)
  • humans (1)
  • patients (1)
  • protein family (2)
  • VDAC2 (8)
  • Sizes of these terms reflect their relevance to your search.

    The BCL-2 protein family govern whether a cell dies or survives by controlling mitochondrial apoptosis. As dysregulation of mitochondrial apoptosis is a common feature of cancer cells, targeting protein-protein interactions within the BCL-2 protein family is a key strategy to seize control of apoptosis and provide favourable outcomes for cancer patients. Non-BCL-2 family proteins are emerging as novel regulators of apoptosis and are potential drug targets. Voltage dependent anion channel 2 (VDAC2) can regulate apoptosis. However, it is unclear how this occurs at the molecular level, with conflicting evidence in the literature for its role in regulating the BCL-2 effector proteins, BAK and BAX. Notably, VDAC2 is required for efficient BAX-mediated apoptosis, but conversely inhibits BAK-mediated apoptosis. This review focuses on the role of VDAC2 in apoptosis, discussing the current knowledge of the interaction between VDAC2 and BCL-2 family proteins and the recent development of an apoptosis inhibitor that targets the VDAC2-BAK interaction. © 2021 The Author(s).


    Zheng Yuan, Grant Dewson, Peter E Czabotar, Richard W Birkinshaw. VDAC2 and the BCL-2 family of proteins. Biochemical Society transactions. 2021 Dec 17;49(6):2787-2795

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 34913469

    View Full Text